J Morera1, A Guillaume1, P Courtheoux2, L Palazzo3, A Rod1, M Joubert1, Y Reznik4. 1. Endocrinology Unit, Centre Hospitalo-Universitaire de Caen, Avenue de la côte de Nacre, CS 30001, 14033, Caen Cedex 9, France. 2. Diagnostic Radiology Unit, Centre Hospitalo-Universitaire de Caen, Avenue de la côte de nacre, CS 30001, 14033, Caen Cedex 9, France. 3. Endoscopic Ultrasound Unit, Trocadero Clinic, 75016, Paris, France. 4. Endocrinology Unit, Centre Hospitalo-Universitaire de Caen, Avenue de la côte de Nacre, CS 30001, 14033, Caen Cedex 9, France. reznik-y@chu-caen.fr.
Abstract
PURPOSE: Preoperative localization of an insulinoma is recommended to improve the cure rate, but non-invasive procedures can fail to detect the tumour. The objective of the study was to assess the performance of a selective arterial calcium stimulation test in the preoperative localization of insulinomas that were not detected by conventional imaging procedures. METHODS: We conducted a monocenter retrospective case review of 13 patients who had endogenous hyperinsulinism and were treated between 1994 and 2013. Patients were selected on the basis of negative or doubtful non-invasive preoperative imaging. A selective arterial calcium stimulation test was performed by pancreatic and hepatic arteriography with selective intra-arterial calcium stimulation and hepatic venous sampling in order to obtain the plasma insulin measurement. We evaluated the efficacy of the test by comparing the results with an endoscopic ultrasound. RESULTS: Twelve of the 13 patients underwent surgery, and the presence of an insulinoma was proven in 11 patients by pathological analysis of the tumour. An endoscopic ultrasound was consistent with surgery in 71.4 % of cases, while selective arterial calcium stimulation was consistent with surgery in 90.9 % and allowed detection of an insulinoma in two additional patients with a negative endoscopic ultrasound. One false-negative and one false-positive arterial calcium test were observed. No adverse events were recorded except transient skin flush following calcium injection in one patient. CONCLUSION: The selective arterial calcium stimulation test is a sensitive diagnostic procedure for localizing insulinomas and may be considered when non-invasive radiological imaging does not allow the detection of an occult insulinoma.
PURPOSE: Preoperative localization of an insulinoma is recommended to improve the cure rate, but non-invasive procedures can fail to detect the tumour. The objective of the study was to assess the performance of a selective arterial calcium stimulation test in the preoperative localization of insulinomas that were not detected by conventional imaging procedures. METHODS: We conducted a monocenter retrospective case review of 13 patients who had endogenous hyperinsulinism and were treated between 1994 and 2013. Patients were selected on the basis of negative or doubtful non-invasive preoperative imaging. A selective arterial calcium stimulation test was performed by pancreatic and hepatic arteriography with selective intra-arterial calcium stimulation and hepatic venous sampling in order to obtain the plasma insulin measurement. We evaluated the efficacy of the test by comparing the results with an endoscopic ultrasound. RESULTS: Twelve of the 13 patients underwent surgery, and the presence of an insulinoma was proven in 11 patients by pathological analysis of the tumour. An endoscopic ultrasound was consistent with surgery in 71.4 % of cases, while selective arterial calcium stimulation was consistent with surgery in 90.9 % and allowed detection of an insulinoma in two additional patients with a negative endoscopic ultrasound. One false-negative and one false-positive arterial calcium test were observed. No adverse events were recorded except transient skin flush following calcium injection in one patient. CONCLUSION: The selective arterial calcium stimulation test is a sensitive diagnostic procedure for localizing insulinomas and may be considered when non-invasive radiological imaging does not allow the detection of an occult insulinoma.
Authors: J A Norton; B Sigel; A R Baker; S E Ettinghausen; T H Shawker; A G Krudy; J L Doppman; S I Taylor; P Gordon Journal: Surgery Date: 1985-03 Impact factor: 3.982
Authors: T Hayashi; H Honda; K Yasumori; A Kawashima; K Kaneko; T Fukuya; Y Tateshi; T Ro; K Masuda Journal: Nihon Igaku Hoshasen Gakkai Zasshi Date: 1995-11
Authors: Michael Gabriel; Clemens Decristoforo; Dorota Kendler; Georg Dobrozemsky; Dirk Heute; Christian Uprimny; Peter Kovacs; Elisabeth Von Guggenberg; Reto Bale; Irene J Virgolini Journal: J Nucl Med Date: 2007-04 Impact factor: 10.057
Authors: Vibha Varma; Laura Tariciotti; Christopher Coldham; Phillipe Taniere; John A Buckels; Simon R Bramhall Journal: Dig Surg Date: 2011-02-04 Impact factor: 2.588
Authors: I Buchmann; M Henze; S Engelbrecht; M Eisenhut; A Runz; M Schäfer; T Schilling; S Haufe; T Herrmann; U Haberkorn Journal: Eur J Nucl Med Mol Imaging Date: 2007-05-23 Impact factor: 9.236
Authors: Jean-Marc Guettier; Anthony Kam; Richard Chang; Monica C Skarulis; Craig Cochran; H Richard Alexander; Steven K Libutti; James F Pingpank; Phillip Gorden Journal: J Clin Endocrinol Metab Date: 2009-02-03 Impact factor: 5.958
Authors: C Mele; A Brunani; B Damascelli; V Tichà; L Castello; G Aimaretti; M Scacchi; P Marzullo Journal: J Endocrinol Invest Date: 2017-07-28 Impact factor: 4.256
Authors: Timothy D Murtha; Beatrice C Lupsa; Sachin Majumdar; Dhanpat Jain; Ronald R Salem Journal: J Gastrointest Surg Date: 2017-05-16 Impact factor: 3.452
Authors: Anna Sowa-Staszczak; Małgorzata Trofimiuk-Müldner; Agnieszka Stefańska; Monika Tomaszuk; Monika Buziak-Bereza; Aleksandra Gilis-Januszewska; Agata Jabrocka-Hybel; Bogusław Głowa; Maciej Małecki; Tomasz Bednarczuk; Grzegorz Kamiński; Aldona Kowalska; Renata Mikołajczak; Barbara Janota; Alicja Hubalewska-Dydejczyk Journal: PLoS One Date: 2016-08-15 Impact factor: 3.240